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determinants of HIV-1 Gag binding
to the plasma membrane
Jiri Vlach and Jamil S. Saad*
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA
Targeting of the Gag polyprotein to the plasma membrane (PM) for assembly is a critical
event in the late phase of immunodeficiency virus type-1 (HIV-1) infection. Gag binding to
the PM is mediated by interactions between the myristoylated matrix (MA) domain and
PM lipids. Despite the extensive biochemical and in vitro studies of Gag andMA binding to
membranes over the last two decades, the discovery of the role of phosphatidylinositol-
4,5-bisphosphate [PI(4,5)P2] in Gag binding to the PM has sparked a string of studies
aimed at elucidating the molecular mechanism of retroviral Gag–PM binding. Electrostatic
interactions between a highly conserved basic region of MA and acidic phospholipids
have long been thought to be the main driving force for Gag–membrane interactions.
However, recent studies suggest that the mechanism is rather complex since other
factors such as the hydrophobicity of the membrane interior represented by the acyl
chains and cholesterol also play important roles. Here we summarize the current
understanding of HIV-1 Gag–membrane interactions at themolecular and structural levels
and briefly discuss the underlying forces governing interactions of other retroviral MA
proteins with the PM.
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Introduction
Prior to assembly on the plasma membrane (PM), the human immunodeficiency virus type-1
(HIV-1) Gag polyprotein adopts a compact “folded over” conformation and exists in the monomeric
or low-order oligomeric states (Datta et al., 2007a, 2011; Kutluay and Bieniasz, 2010; Kutluay et al.,
2014). Whereas it is established that the nucleocapsid (NC) domain of Gag specifically recognizes
motifs in the viral RNA genome for packaging (Jouvenet et al., 2009; Kutluay et al., 2014), there is
compelling evidence that the matrix (MA) domain also binds to cellular RNA to prevent premature
Gag targeting to intracellular membranes (Figure 1; Chukkapalli et al., 2010, 2013; Chukkapalli and
Ono, 2011; Hogue et al., 2012; Inlora et al., 2014; Kutluay et al., 2014; Olety and Ono, 2014). Upon
transport of Gag to the PM, the interaction of MA with RNA is exchanged for an interaction of MA
with PM components (Figure 1; Chukkapalli et al., 2010, 2013; Chukkapalli and Ono, 2011; Hogue
et al., 2012; Inlora et al., 2014; Olety and Ono, 2014). This molecular switch induces an extended
conformation of Gag, leading to formation of high-order Gag oligomers on the PM (Datta et al.,
2007a,b, 2011; Munro et al., 2014). The key to understanding this essential switch is elucidating at
the molecular level the interaction of MAwith specific PM components. Our current understanding
Abbreviations: MA, matrix protein; NMR, nuclear magnetic resonance; PS, phosphatidylserine;
PI(4,5)P2, phosphatidylinositol-4,5-bisphosphate.
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FIGURE 1 | The MA domain of Gag is involved in multiple interactions including RNA and lipids on the inner leaflet of the PM.
of Gag–PM interaction is incomplete because of the lack ofmolec-
ular details on how various membrane components contribute to
the overall binding and how they control this molecular switch.
Factors that Control HIV-1 Gag Assembly
on the PM
For most retroviruses, assembly of the Gag proteins occurs on the
PM of the infected cell (Ono et al., 2004; Jouvenet et al., 2006,
2008; Finzi et al., 2007;Welsch et al., 2007; Chukkapalli et al., 2008,
2010; Chu et al., 2010; Chukkapalli and Ono, 2011). The role of
MA domain in Gag–PM binding is indispensable. Several factors
can influence Gag–membrane binding including the myristoyl
(myr) group, a conserved basic region in MA, protein multimer-
ization, cellular RNA, and phosphatidylinositol-4,5-bisphosphate
[PI(4,5)P2] (Ono and Freed, 1999; Ono et al., 2004; Jouvenet et al.,
2006; Dalton et al., 2007; Chukkapalli et al., 2008, 2010, 2013;
Alfadhli et al., 2011; Chukkapalli and Ono, 2011; Ghanam et al.,
2012). The finding that Gag binds to membranes more efficiently
than the isolated MA protein led to the hypothesis that the myr
group is exposed in Gag and sequestered in the MA protein,
which has become known as “the myr switch mechanism” (Zhou
and Resh, 1996; Spearman et al., 1997; Hermida-Matsumoto and
Resh, 1999; Ono and Freed, 1999; Paillart and Gottlinger, 1999).
For over two decades, biochemical, in vivo, in vitro, and genetic
data have provided invaluable insights on multiple factors that
modulate Gag–membrane binding. However, only recently the
molecular and structural determinants of this interaction have
begun to emerge (Saad et al., 2006, 2007b, 2008; Shkriabai et al.,
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2006; Chukkapalli et al., 2008, 2010, 2013; Chukkapalli and Ono,
2011; Prchal et al., 2012; Vlach and Saad, 2013). Nuclear mag-
netic resonance (NMR) and analytical ultracentrifugation studies
revealed that the myr group can adopt sequestered and exposed
conformations in the MA protein, that the MA protein resides in
monomer-trimer equilibrium, and that myr exposure is coupled
with protein trimerization (Tang et al., 2004; Saad et al., 2007b).
Exposure of the myr group is also modulated by other factors
including the solution pH, inclusion of the CA domain, and
binding of calmodulin (Tang et al., 2004; Fledderman et al., 2010;
Ghanam et al., 2010). There is now convincing evidence that bind-
ing ofRNA toMApreventsGag from interactingwith intracellular
membranes (Chukkapalli et al., 2010, 2013; Chukkapalli andOno,
2011; Inlora et al., 2014). As a consequence, RNA is considered
as a negative regulator of Gag–membrane binding. Recent studies
have shown that the MA domain binds almost exclusively to
specific tRNAs in the cytosol (Kutluay et al., 2014). Incorporation
of PI(4,5)P2 in membranes inhibits the interaction between MA
and cellular RNA (Chukkapalli et al., 2010, 2013; Chukkapalli and
Ono, 2011). Binding of Gag to membranes induces an extended
conformation in the absence (Datta et al., 2011) or presence (Datta
et al., 2007b) of inositol phosphates. Altogether, these studies
indicate that particle assembly is regulated by coordinated inter-
actions between the MA and NC domains of Gag with RNA and
membrane lipids.
Structural Studies of HIV-1 MA Binding
to PM Lipids
Proper targeting of HIV-1 Gag to the PM is dependent on specific
interactions between the MA domain and PI(4,5)P2 (Ono et al.,
2004; Chukkapalli et al., 2008, 2010; Chukkapalli and Ono, 2011;
Inlora et al., 2014). The most abundant form of PI(4,5)P2 con-
tains saturated 18-carbon 10 and 20-carbon unsaturated 20 fatty
acid chains (Dudley and Spector, 1986), which promote micelle
formation in aqueous solution (Janmey et al., 1987). Interactions
of HIV-1 Gag andMA with PI(4,5)P2 have been detected by mass
spectrometric protein footprinting (Shkriabai et al., 2006). Titra-
tion of native PI(4,5)P2 intoMA samples led to severe broadening
and loss of NMR signals. Therefore, soluble analogs of PI(4,5)P2
with truncated 10- and 20-acyl chains (C4 or C8) have been used
(Saad et al., 2006, 2007a, 2008). NMR studies have shown that
soluble analogs of PI(4,5)P2 bind directly to HIV-1 MA, induc-
ing a conformational change that promotes myr exposure (Saad
et al., 2006). The solution structure of the MA–PI(4,5)P2 complex
revealed that the 20-acyl chain is inserted in a hydrophobic cleft,
whereas the inositol group is packed against a highly basic region
of MA (Figure 2A). The 10-acyl chain, however, is not involved in
binding and is exposed to solvent. It was suggested that PI(4,5)P2
can function as both an allosteric trigger for myr exposure and
as a direct membrane anchor (Saad et al., 2006). The involvement
of the acyl chain of PI(4,5)P2 in MA and Gag binding has been
confirmed by surface plasmon resonance methods (Anraku et al.,
2010). Based on the NMR studies, a structural model for Gag
bound to PM has been proposed. In this model, MA is anchored
to the membrane by the myr group and 10-acyl chain of PI(4,5)P2,
which bracket a patch of conserved basic residues that can interact
with the negatively charged surface of PM (Saad et al., 2006).
A molecular model of MA bound to native PI(4,5)P2 shows that a
longer 20-acyl chain (18 carbons) can be accommodated into the
hydrophobic cleft (Saad et al., 2006). Structural studies have yet
to determine the precise mode of MA binding to native PI(4,5)P2
within the context of a membrane bilayer.
In addition to PI(4,5)P2, other lipids have been implicated in
HIV-1 Gag–membrane binding (Dalton et al., 2007; Ono, 2010a;
Waheed and Freed, 2010; Chan et al., 2011; Chukkapalli and
Ono, 2011; Chukkapalli et al., 2013). The affinity of Gag and
MA to membranes is increased upon increasing the stoichiom-
etry of phosphatidylserine (PS; Ehrlich et al., 1996; Zhou and
Resh, 1996; Scarlata et al., 1998; Dalton et al., 2007; Chukkapalli
et al., 2008, 2010, 2013; Alfadhli et al., 2009; Chan et al., 2011).
NMR studies on HIV-1 MA binding to soluble analogs of PM
lipids revealed that PS, phosphatidylethanolamine (PE) and phos-
phatidylcholine (PC) bind directly to MA via a distinct site that
is adjacent to the PI(4,5)P2 binding site (Vlach and Saad, 2013).
All three phospholipids interact with MA via sequestration of
the 20-acyl chain into a cavity formed by hydrophobic residues
in helices a2 and a3, leaving the 10-acyl exposed (Figure 2B).
Surprisingly, the polar heads of PE, PS, or PC do not appear to
play amajor role in stabilizing the complex. Structural studies have
been conducted with single lipids. It is likely that in a membrane
environment the lipid polar heads will orient to make favorable
electrostatic contacts with the basic domain of MA. Consistent
with the hydrophobic nature of binding, the affinities of all three
phospholipids to MA increased by two orders of magnitude upon
extending the acyl chains from hexanoyl to octanoyl (Vlach and
Saad, 2013). Intriguingly, the myr group is readily exposed when
MA is bound to membrane mimetics such as micelles and bicelles
in the absence of PI(4,5)P2. Exposure of the myr group does not
appear to be triggered by an allosteric mechanism as in the case
of PI(4,5)P2 binding, but rather by the mere presence of a lipid
agglomerate. Based on these studies, we have proposed a trio
engagement model by which HIV-1 Gag is anchored to the PM
via the 10-acyl chains of PI(4,5)P2 and PS/PE/PC lipids, and the
myr group, which collectively bracket a basic patch projecting
toward the polar leaflet of the membrane (Vlach and Saad, 2013).
Exposure of the myr group by a membrane-like environment,
independent of PI(4,5)P2 binding, was also observed in a reverse
micellar system (Valentine et al., 2010). Spontaneous exposure
of the myr group prior to association to membranes has also
been observed by using coarse-grained simulation approaches
(Charlier et al., 2014). The authors reported that insertion of the
myr group into the bilayer is necessary for the orientation of MA
to allow for the experimentally identified region ofMA to interact
with the PI(4,5)P2 head group. Flipping of the lipid acyl chain out
of the membrane environment to the hydrophobic groove in MA
was, however, not observed. Further studies are needed to answer
yet unresolved questions: What is the actual trigger and mecha-
nism of myr exposure in vivo? Are acyl chains of either PI(4,5)P2
or other phospholipids involved in MA binding to the PM? The
Vogt lab has recently shown that Gag and MA strongly preferred
lipids with both acyl chains unsaturated over those with one
chain unsaturated (Dick et al., 2012). Furthermore, Gag can sense
cholesterol in the membrane bilayer allowing for a more efficient
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FIGURE 2 | (A–D) Close-up views of structures of HIV-1, HIV-2, and M-PMV
MA proteins bound to lipids. MA proteins are shown in ribbon and surface
representations with residues implicated in binding shown as sticks.
Phospholipids are shown as green [PI(4,5)P2] or blue (PC) sticks and their acyl
chains involved in binding are shown in cyan. (A) HIV-1 myr( )MA bound to
di-C8-PI(4,5)P2 (PDB ID: 2H3V). (B) HIV-1 myr( )MA bound to di-C8-PC (PDB
ID: 2LYA). (C) HIV-2 MA bound di-C4-PI(4,5)P2 (PDB ID: 2K4I). (D) M-PMV MA
bound to di-C8-PI(4,5)P2 structure provided by Prchal et al. (2012).
(E) Cryoelectron microscopy reconstruction of HIV-1 immature particle in a
section with (left) or without (right) Gag polyprotein present. Used with
permission [Copyright (2009) National Academy of Sciences, USA (Briggs et al.,
2009)]. (F) A schematic representation of potential mechanisms for Gag binding
to the PM for different retroviruses. Gag binding to membranes is regulated by
PI(4,5)P2 and RNA for some but not all retroviruses. Binding of Gag to
membranes via the MA domain displaces RNA, which binds non-specifically to
the basic region of MA. Data are not in agreement on the role of PI(4,5)P2 in MLV
Gag binding to the PM. For EIAV, Gag binding to membranes appears to have
no specific requirement for PI(4,5)P2 since other phosphoinositides may also
play a role. For M-PMV, Gag assembly occurs in the cytoplasm prior to
transport to the PM where MA specifically recognizes PI(4,5)P2.
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Gag binding to membranes (Dick et al., 2012). However, it is not
yet known whether cholesterol can bind directly to Gag. Recent
studies have also suggested that interactions can occur between
the isolated NC and p6 domains of Gag with membrane models
(Solbak et al., 2013; Kempf et al., 2015). However, the biological
significance of these interactions has yet to be established. Further
studies are needed to determine the synergy and interplay between
PM components and their role in modulating the conformational
switch of HIV-1 Gag during assembly (Ono, 2010b).
Other Retroviral Gag and MA Interactions
with Lipids and Membranes
LikeHIV-1, the site ofHIV-2 assembly in vivo is also dependent on
PI(4,5)P2 (Saad et al., 2008). Structural studies show that the HIV-
1 and HIV-2 MA structures are very similar and that PI(4,5)P2
binds to both proteins in an identical manner (Figures 2A,C; Saad
et al., 2008). However, in contrast to HIV-1MA the position of the
myr group in HIV-2 MA is less sensitive to factors that modulate
myr exposure in HIV-1 MA such as protein concentration and
binding of di-C4-PI(4,5)P2 (Saad et al., 2008). Data are not in
agreement on the role of PI(4,5)P2 in other retroviruses. Previ-
ous studies have shown that murine leukemia virus (MLV) Gag
targeting to the PM is mediated by PI(4,5)P2 and PS, suggesting
a synergy between these two lipids to modulate Gag–PM binding
(Hamard-Peron et al., 2010). The Ono laboratory, however, has
recently shown that MLV Gag–PM binding is not dependent on
PI(4,5)P2 (Inlora et al., 2014). The Gag proteins of Rous sarcoma
virus (RSV) and equine infectious anemia virus (EIAV) lack the
myr group and it is thought that Gag–membrane interaction is
driven mainly by electrostatic interactions (Erdie andWills, 1990;
Provitera et al., 2000; Dalton et al., 2005; Chen et al., 2008; Fernan-
des et al., 2011). Association of RSV MA and Gag with liposomes
of defined composition is dependent on the presence of a biolog-
ically relevant concentration of negatively charged lipids like PS
(Dalton et al., 2005). TheVogt laboratory has shown that RSVGag
has no specific requirement for PI(4,5)P2 for PM association in
vivo or liposome interaction in vitro (Chan et al., 2011). Parent
and colleagues, however, have shown that depletion of intra-
cellular PI(4,5)P2 and phosphatidylinositol-(3,4,5)-trisphosphate
[PI(3,4,5)P3] levels impaired RSVGag PM localization (Nadaraia-
Hoke et al., 2013). It was suggested that differences are partially
attributed to the sensitivity of assays utilized in these studies
(Dick and Vogt, 2014). Most recent in vitro and in vivo studies
from the Ono laboratory have shown that Gag–membrane bind-
ing via RSV MA is both PI(4,5)P2 dependent and is susceptible
to RNA-mediated inhibition (Inlora et al., 2014). No structural
studies are currently available on how RSV MA interacts with
PM lipids.
The Carter laboratory has reported that a soluble analog of
PI(4,5)P2 interacts directly with EIAV MA (Chen et al., 2008).
More recently, it was shown that EIAV Gag is not only present
on the PM but also in compartments enriched in phosphatidyli-
nositol 3,5-biphosphate [PI(3,5)P2] (Fernandes et al., 2011). In
contrast to HIV-1, release of EIAV particles is not significantly
diminished by co-expression with 5-phosphatase IV, which may
suggest that PI(4,5)P2 does not play a critical role in EIAV Gag
assembly on the PM. Additional NMR studies have shown that
phosphatidylinositol 3-phosphate [PI(3)P] binds to EIAV MA
tighter than that of PI(4,5)P2 (Fernandes et al., 2011). Altogether,
it is likely that EIAV Gag membrane targeting proceeds via a
mechanism that is different from that of HIV-1, HIV-2, MLV, or
RSV.
The Gag precursor of deltaretrovirus human T-lymphotropic
virus type 1 (HTLV-1), Pr53Gag, localizes at the cell surface and
intracellular compartments in HeLa cells (Le Blanc et al., 1999,
2002; Heidecker et al., 2004). It has been shown that subcellular
localization of HTLV-1 Gag and VLP release are minimally or not
sensitive to depletion of PI(4,5)P2 from the PM, suggesting that
the interaction of HTLV-1 MA with PI(4,5)P2 is not essential for
HTLV-1 Gag–membrane binding and particle assembly (Inlora
et al., 2011, 2014). Single amino acid substitutions that confer a
large basic patch rendered HTLV-1 MA susceptible to the RNA-
mediated block, a phenotype similar to that observed for HIV-1
and RSV. It remains unknown whether other PM lipids play
important roles in HTLV-1 Gag assembly as further studies are
needed to identify the precisemolecular requirements forHTLV-1
Gag binding to membranes.
Assembly and particle production of Mason-Pfizer monkey
virus (M-PMV) is perhaps the most distinct from all cases dis-
cussed above.M-PMV is thought to catalyze themembrane envel-
opment of a preassembled spherical capsid shell to release infec-
tious virions (Sfakianos and Hunter, 2003). Assembly of M-PMV
capsids occurs in a pericentriolar region of the cytoplasm prior to
transport to the PM for budding. It is thought that both MA and
CA domains of M-PMVGag interact with the PM (Sfakianos and
Hunter, 2003). Initial evidence for a potential role of PI(4,5)P2 in
M-PMV Gag–PM binding has been reported by Hunter and col-
leagues (Stansell et al., 2007). Depletion of PI(4,5)P2 from the PM
led to dramatic decrease of particle release fromM-PMV infected
cells. Direct interaction betweenM-PMVMAand a soluble analog
of PI(4,5)P2 has been detected (Prchal et al., 2012). The solution
structure of M-PMV MA protein and its binding mode to di-C8-
PI(4,5)P2 have been determined by NMR and molecular docking
methods (for more details, see Prchal et al., 2012, 2014). The
hallmark of the bindingmode is the deep penetration of one of the
C8 chains into a hydrophobic pocket formed between helices a1,
a2, and a4 (Figure 2D). The position of themyr group ofM-PMV
MA was not affected by di-C8-PI(4,5)P2 binding and remained
sequestered in the protein core. Interestingly, no binding was
detected between the unmyristoylated MA protein of M-PMV
and soluble analogs of PI(4,5)P2 (Prchal et al., 2012). The authors
attributed this observation to the structural differences between
MA and unmyristoylated MA, in which the hydrophobic cavity
is absent in the latter. Altogether, the mechanisms of retroviral
Gag assembly appear to be complex and require more detailed
investigation at the molecular level (Figure 2F).
Gaps in Our Understanding of Gag Binding
to the PM and Future Directions
Structural studies of HIV-1 MA interactions with PI(4,5)P2, PS,
PE, and PC have provided novel insights into themolecularmech-
anism of Gag assembly on the PM. These studies have utilized
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lipids with truncated acyl chains. The precise mode of binding
of native lipids with longer chains to MA has yet to be eluci-
dated. The lack of an atomic snapshot for MA when bound to
membranes containing physiologically relevant lipid composi-
tion remains a major gap in our understanding of virus assem-
bly. Investigation of the molecular rearrangements of Gag in
the immature and mature HIV particles have heavily relied on
cryoelectron microscopy (cEM) data. Although details of the
hexameric CA lattice exist, cEM studies have not provided a
clear picture of the membrane-associated MA domain of Gag in
either of the immature or mature particles (Fuller et al., 1997;
Briggs et al., 2006, 2009; Wright et al., 2007). cEM data show
that the membrane bilayer is thicker in regions where the Gag
lattice is present and that MA density appears to “penetrate”
the membrane bilayer (Figure 2E; Briggs et al., 2009). Earlier
cEM tomography studies have suggested that the membrane-
bound MA domain lacks periodicity (Wright et al., 2007). We
believe that future studies may benefit from hybrid structural
and biophysical methods to construct a model of Gag and/or
MA bound to membranes. These may include small-angle x-ray
scattering, atomic force microscopy and high-resolution cEM.
Understanding the molecular basis of Gag assembly will not only
shed light on the assembly of HIV-1 particles but will likely
provide insight into the control of assembly in other retroviruses
that assemble at the PM. Such studies are of great importance
as these interactions may serve as pharmacological targets to
inhibit HIV assembly. Structure-based studies have identified
small molecule inhibitors that bind to the PI(4,5)P2 site of HIV-
1 MA and possess modest potency in reducing virus production
(Zentner et al., 2013a,b; LaPlante et al., 2014). Although consid-
ered weak binders, these inhibitors may serve as a template for
future studies aimed at the development of novel inhibitors of
retroviral assembly.
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